Q32 BIO
Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases. Q32 Bio is addressing dysregulation to help patients take back control of their lives in diseases with few to no treatment options, or those diseases where current therapeutics provide inadequate relief. Q32 Bio consists of a team of scientists and industry veterans with strong expertise in immunology. The team has a strong track record of discovering and developing new and innovative therapies.
Q32 BIO
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.q32bio.com
Total Employee:
11+
Status:
Active
Total Funding:
106 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Font Awesome
Similar Organizations
Abalone Bio
Abalone Bio is an early stage biotech start-up that develops antibody drugs for the treatment of diseases.
Akarna Therapeutics
At Akarna, our mission is to develop best-Âin-Âclass treatments for NASH and other chronic liver diseases
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
DermBiont
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Current Advisors List
Board_member
Board_member
Board_member
2020-01-01
Board_member
Current Employees Featured
Michael Broxson CEO @ Q32 Bio
CEO
Shelia Violette Founder, Chief Scientific Officer, and President of Research @ Q32 Bio
Founder, Chief Scientific Officer, and President of Research
Susan Kalled Vice President of Biology @ Q32 Bio
Vice President of Biology
Maria Marzilli Head of Corporate Development @ Q32 Bio
Head of Corporate Development
Kathryn Golden Head of Chemistry, Manufacturing, and Controls @ Q32 Bio
Head of Chemistry, Manufacturing, and Controls
Jason Campagna Chief Medical Officer @ Q32 Bio
Chief Medical Officer
2021-03-01
Founder
Investors List
University of Colorado
University of Colorado investment in Series B - Q32 Bio
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Q32 Bio
Sanofi Ventures
Sanofi Ventures investment in Series B - Q32 Bio
Atlas Venture
Atlas Venture investment in Series B - Q32 Bio
Children’s Hospital Colorado
Children’s Hospital Colorado investment in Series B - Q32 Bio
Acorn Bioventures
Acorn Bioventures investment in Series B - Q32 Bio
Abingworth
Abingworth investment in Series B - Q32 Bio
OrbiMed
OrbiMed investment in Series B - Q32 Bio
Abingworth
Abingworth investment in Series A - Q32 Bio
Atlas Venture
Atlas Venture investment in Series A - Q32 Bio
Official Site Inspections
http://www.q32bio.com Semrush global rank: 1.28 M Semrush visits lastest month: 23.09 K
- Host name: 161.52.148.146.bc.googleusercontent.com
- IP address: 146.148.52.161
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Q32 Bio"
Q32 Bio
Bempikibart (ADX-914) Adaptive System Modulator. Bempikibart, Q32 Bio’s most advanced product candidate, is a fully human anti–interleukin-7 receptor alpha (IL-7Rα) antagonist …See details»
Q32 Bio - Crunchbase Company Profile & Funding
Contact Email info@q32bio.com Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases. …See details»
Q32 Bio Inc. - LinkedIn
To view our most recent press release and learn more, please visit www.q32bio.com. #ASN2024 #Q32Bio #QTTB. 47 Like Comment Share Q32 Bio Inc. 4,422 followers ...See details»
Q32 BIO INC. Company Profile | Cambridge, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Q32 BIO INC. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Q32 Bio - Overview, News & Similar companies | ZoomInfo.com
Q32 Bio has announced that Saul Fink has joined the organization as Chief Technology Officer. Previously Fink served as Senior VP, Pharmaceutical & Nonclinical Development for …See details»
Q32 Bio, a Clinical Stage Biotechnology Company Focused on …
Sep 20, 2022 Q32 Bio is currently conducting a first-in-human, Phase 1, ascending dose (SAD/MAD) clinical study of ADX-097 for the treatment of complement disorders. For more …See details»
Q32 Bio Inc. (LON:0T6G) Company Profile & Overview
Feb 28, 2025 Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory …See details»
Q32 Bio Company Profile -Sales, Contacts, Competitors – Buzzfile
This organization primarily operates in the Hospital and Health Services Consultant business / industry within the Engineering, Accounting, Research, and Management Services sector. This …See details»
Q32 Bio Company Profile - Office Locations, Competitors ... - Craft
Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases. The company has a product pipeline including a monoclonal …See details»
Q32 Bio Inc Locations - Headquarters & Offices - GlobalData
Www.q32bio.com. Other Locations & Subsidiaries. Homology Medicines Security Corp United States of America. Get exclusive access to more locations data when ...See details»
Q32 Bio Inc Company Profile - Overview - GlobalData
Website www.q32bio.com Telephone 1 781 9990232. No of Employees 42. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange QTTB (NASD) EPS XYZ. Net …See details»
Q32 Bio (QTTB) Company Profile & Description - Stock Analysis
6 days ago Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases …See details»
Q32 Bio Inc. Overview | SignalHire Company Profile
Q32 Bio is a biotechnology company developing therapeutics targeting powerful regulators of the innate and adaptive immune systems, with the goal of re-balancing the immune system in …See details»
Q32 Bio - F6S
Q32bio.com About Q32 Bio Q32 Bio is a biotechnology company developing therapeutics targeting powerful regulators of the innate and adaptive immune systems, with the goal of re …See details»
Q32 Bio - LifeScienceHistory.com
Company Description. Q32 Bio is developing drugs targeting powerful regulators of both the innate and adaptive immune systems with the goal of re-balancing the immune system.See details»
Q32 Bio - VentureRadar
"Q32 Bio has developed an integrated portfolio of therapies to modulate the innate and adaptive immune responses. Our team’s mission is to bring safer, more efficacious therapeutics to …See details»
Q32 Bio, a Clinical Stage Biotechnology Company Focused on …
Sep 20, 2022 For more information, please visit www.Q32bio.com. Q32 Bio Contacts: Investors: Brendan Burns Media: Sarah Sutton Argot Partners 212.600.1902 [email protected] SOURCE …See details»
Q32 Bio Announces Strategic Restructuring to Focus on …
Feb 10, 2025 Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced …See details»
Q32 Bio Doses First Patients in Both Part A Open-Label Extension …
-- SIGNAL-AA Part B topline data readout on-track for 1H'26 --WALTHAM, Mass., April 16, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio" or the "Company"), a clinical stage …See details»
Q32 Bio Doses First Patients in Both Part A Open-Label Extension …
3 days ago Investors and others should note that Q32 Bio communicates with its investors and the public using its website www.Q32Bio.com, including, but not limited to, the Company's …See details»